• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Viking Therapeutics - Articles and news items

Viking submits IND for VK2809 in hypercholesterolemia

Industry news / 18 November 2015 / Victoria White

VK2809 is a novel, orally available small molecule thyroid receptor agonist that possesses selectivity for liver tissue as well as the beta receptor subtype…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +